ask="4.74"
ask_size="200"
average_daily_volume="577344"
bid="4.50"
bid_size="1000"
book_value="2.30"
change="-0.16"
change_from_200_day_moving_average="-0.01"
change_from_50_day_moving_average="-0.29"
change_from_52_week_high="-2.29"
change_From_52_week_low="1.46"
change_in_percent="-3.39%"
close="4.56"
dividend_pay_date="12/30/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.68"
ebitda="-43.09M"
eps_estimate_current_year="-1.47"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.84"
ex_dividend_date="12/31/2013"
float_shares="40197000"
high="4.78"
high_52_weeks="6.85"
last_trade_date="1/5/2017"
last_trade_price="4.56"
last_trade_size="3042"
last_trade_time="4:00pm"
low="4.53"
low_52_weeks="3.10"
market_capitalization="298.35M"
moving_average_200_day="4.57"
moving_average_50_day="4.85"
name="Aralez Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="9.83"
open="4.73"
pe_ratio="N/A"
peg_ratio="-0.10"
percent_change_from_200_day_moving_average="-0.13%"
percent_change_from_50_day_moving_average="-6.01%"
percent_change_from_52_week_high="-33.43%"
percent_change_from_52_week_low="+47.10%"
previous_close="4.72"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.05"
price_per_sales="7.68"
revenue="40.23M"
shares_outstanding="65427000"
short_ratio="6.27"
stock_exchange="NMS"
symbol="ARLZ"
volume="581025"
weeks_range_52="3.10 - 6.85"
